Business Context and Reporting Period
Company: On Assignment, Inc. (Note: Input metadata listed "Everforth Inc," but the filing text identifies the registrant as On Assignment, Inc.)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2010
Business Overview: A diversified professional staffing firm operating in four segments: Life Sciences, Healthcare, Physician, and IT and Engineering. The company provides contract, contract-to-permanent, and direct placement services.
Key Financial Metrics
| Metric (in thousands) | Q3 2010 | Q3 2009 | 9 Months 2010 | 9 Months 2009 |
|---|---|---|---|---|
| Revenues | $116,141 | $98,053 | $316,913 | $316,689 |
| Gross Profit | $41,103 | $32,773 | $107,222 | $103,154 |
| Gross Margin | 35.4% | 33.4% | 33.8% | 32.6% |
| Operating Income | $7,442 | $4,322 | $11,766 | $11,589 |
| Net Income | $3,163 | $1,454 | $3,801 | $3,672 |
| Diluted EPS | $0.09 | $0.04 | $0.10 | $0.10 |
| Cash & Equivalents | $30,278 | $25,974 | $30,278 | $35,068 |
| Long-Term Debt | $77,913 | $77,913 | $77,913 | $77,913 |
| Working Capital | $61,617 | $62,238 | $61,617 | $62,238 |
Note: Working Capital calculated as Total Current Assets ($102,372) minus Total Current Liabilities ($40,755).
Material Changes vs. Prior Period
- Revenue Growth: Q3 2010 revenue increased 18.4% year-over-year, driven by strong performance in IT and Engineering (+48.9%) and Life Sciences (+33.1%). This growth offset declines in Healthcare (-5.5%) and Physician (-16.8%) segments.
- Margin Expansion: Consolidated gross margin expanded to 35.4% in Q3 2010 from 33.4% in Q3 2009, attributed to a shift in mix toward higher-margin segments and increased direct hire fees.
- Acquisitions: The company completed two acquisitions in 2010: The Cambridge Group Ltd. (April) and Sharpstream Holdings Ltd. (July). These contributed $2.6 million and $1.6 million respectively to Q3 2010 revenues.
- Cash Flow: Net cash provided by operating activities decreased to $20.4 million for the nine months ended Sept 30, 2010, compared to $40.6 million in the prior year, primarily due to an increase in accounts receivable.
Guidance, Outlook, and Risks
- Goodwill Impairment Risk: Management identified a triggering event for the Physician reporting unit due to a 10% decline in revised revenue forecasts and market capitalization below book value. A Step 1 impairment analysis was performed as of September 30, 2010, which did not indicate impairment. However, the company notes that fair value estimates are sensitive to discount rate changes and cash flow projections.
- Outlook: Management expects revenue growth to continue organically and through strategic acquisitions. The company anticipates the economic recovery to continue through 2010 and 2011 for most segments, though the Physician and Nurse Travel segments are expected to see recovery begin in 2011.
- Debt Covenants: The company is in compliance with all financial covenants under its credit facility. It is in the process of replacing its credit facility to lower interest rates.
- Subsequent Event: On October 25, 2010, the Board authorized a corporate stock repurchase program over a four-year period.
Investor Verification Checklist
- Goodwill Valuation: Verify the assumptions used in the Physician segment goodwill impairment test, specifically the 14.0% discount rate and revenue growth forecasts for 2011.
- Acquisition Integration: Monitor the performance of the Cambridge and Sharpstream acquisitions to ensure they meet the earn-out criteria (up to $2.3M and $1.4M respectively).
- Healthcare Segment Trends: Assess the sustainability of the revenue decline in the Healthcare and Physician segments, which are attributed to economic conditions and reduced elective procedures.
- Debt Refinancing: Track the progress of replacing the current credit facility to confirm potential interest rate reductions.
- Accounts Receivable: Review the aging of accounts receivable, which increased significantly and contributed to the decline in operating cash flow.